Kalle Landerholm
-
- Lung Cancer Research Studies 6
- Pancreatic and Hepatic Oncology Research 6
- Gastroenterology top 10%
-
- Neuroendocrine Tumor Research Advances 10
- Microscopic Colitis 6
-
- Diverticular Disease and Complications 7
-
- Neuroblastoma Research and Treatments 5
-
- Inflammatory Bowel Disease 14
-
- Genetic factors in colorectal cancer 5
- Co-authors
- Johannes JärhultRoland E. AnderssonSture FalkmerPär MyrelidNiklas ZarPeter AnderssonUlf HammarNils Wierup
- Cited by
- OncologyGastroenterologyEpidemiology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Clinical Cancer Research (1 paper)The American Journal of Gastroenterology (1 paper)
- Partner nations
- SwedenUnited KingdomNorway
In The Last Decade
Kalle Landerholm
42 papers receiving 513 citations
Peers
Comparison fields: 5 of 53
- Oncology 223
- Gastroenterology 40
- Epidemiology 234
- Surgery 229
- Neurology 75
Countries citing papers authored by Kalle Landerholm
This map shows the geographic impact of Kalle Landerholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalle Landerholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalle Landerholm more than expected).
Fields of papers citing papers by Kalle Landerholm
This network shows the impact of papers produced by Kalle Landerholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalle Landerholm. The network helps show where Kalle Landerholm may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kalle Landerholm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 16 | |
| 14 | 2019 | 21 | |
| 15 | 2019 | 9 | |
| 16 | 2018 | 8 | |
| 17 | 2016 | 51 | |
| 18 | 2015 | 2 | |
| 19 | 2014 | 2 | |
| 20 | 2010 | 15 |
About Kalle Landerholm
Kalle Landerholm is a scholar working on Oncology, Genetics and Epidemiology, having authored 44 papers that have together received 519 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (14 papers), Neuroendocrine Tumor Research Advances (10 papers), Diverticular Disease and Complications (7 papers), Lung Cancer Research Studies (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Microscopic Colitis (6 papers), Neuroblastoma Research and Treatments (5 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Oncology (223 citations), Gastroenterology (40 citations) and Epidemiology (234 citations). Kalle Landerholm has collaborated with scholars based in Sweden, United Kingdom and Norway. Frequent co-authors include Johannes Järhult, Roland E. Andersson, Sture Falkmer, Pär Myrelid, Niklas Zar, Peter Andersson, Ulf Hammar, Nils Wierup, Caroline Nordenvall and Thomas Pinkney. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.